Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Novel therapeutic strategies are urgently needed for advanced metastatic prostate cancer (PCa). Phytochemicals used in Traditional Chinese Medicine seem to exhibit tumor suppressive properties. Therefore, the therapeutic potential of artesunate (ART) on the progressive growth of therapy-sensitive (p...

Full description

Bibliographic Details
Main Authors: Olesya Vakhrusheva, Holger H. H. Erb, Vitus Bräunig, Sascha D. Markowitsch, Patricia Schupp, Patrick C. Baer, Kimberly Sue Slade, Anita Thomas, Igor Tsaur, Martin Puhr, Zoran Culig, Jindrich Cinatl, Martin Michaelis, Thomas Efferth, Axel Haferkamp, Eva Juengel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
prostate cancer (PCa)
docetaxel (DX) resistance
artesunate (ART)
Traditional Chinese Medicine (TCM)
growth inhibition
apoptosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.789284/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.789284/full

Similar Items